Neuropsychiatric update: neuroimaging schizophrenia.

Psychopharmacol Bull. 2007;40(4):156-67.Neuropsychiatric update: neuroimaging schizophrenia.Kile SJ., Psychopharmacol Bull. 2007;40(4):156-67.Neuropsychiatric update: neuroimaging schizophrenia.Kile SJ., 2007 Jul 20

Investigators

Shawn Kile, MD

Abstract

Abstract
Neuroimaging has revitalized the quest for the neurobiology of schizophrenia. The various neuroimaging modalities used in research are described including CT, MRI, PET, SPECT, fMRI, and DTI. Prominent and consistent neuroanatomical findings in the neuroimaging literature of schizophrenia are outlined. These findings, including enlargement of the lateral ventricles, undersized superior temporal gyrus, and prefrontal abnormalities, are supported with neuropathological studies of schizophrenia. Additionally, these findings are correlated with the clinical symptoms of schizophrenia. Neurochemical imaging studies of schizophrenia are reviewed and noted to support dopaminergic dysregulation consistent with the dopamine hypothesis. Finally, current and near-future clinical uses of neuroimaging are described.

PMID:18227785[PubMed - indexed for MEDLINE]

Pubmed Abstract

Pubmed AbstractOpens New Window

Associated Topics

Neurological Disorders

Related Publications

Conducting a pilot randomized controlled trial of community-based mindfulness-based stress reduction versus usual care for moderate-to-severe migraine: protocol for the Mindfulness and Migraine Study (M&M).

Pressman A, Law H, Stahl R, Scott A, Jacobson A, Dean L, Sudat S, Obillo A, Avins A.
Trials 2019;20:257.
2019 May 06

Prevalence of migraine in a diverse community--electronic methods for migraine ascertainment in a large integrated health plan.

Pressman A, Jacobson A, Eguilos R, Gelfand A, Huynh C, Hamilton L, Avins A, Bakshi N, Merikangas K.
Cephalalgia. 36(4):325-34. doi: 10.1177/0333102415590242. Epub 2015 Jun 11.
2016 Apr 01